Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer ; volume:24 ; number:1 ; day:29 ; month:2 ; year:2024 ; pages:1-11 ; date:12.2024
Cancer imaging ; 24, Heft 1 (29.2.2024), 1-11, 12.2024

Creator: Deng, Tingting
Liang, Jianwen
Yan, Cuiju
Ni, Mengqian
Xiang, Huiling
Li, Chunyan
Ou, Jinjing
Lin, Qingguang
Liu, Lixian
Tang, Guoxue
Luo, Rongzhen
An, Xin
Gao, Yi
Lin, Xi

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40644-024-00676-w

URN: urn:nbn:de:101:1-2405070903011.467533186743

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Deng, Tingting
Liang, Jianwen
Yan, Cuiju
Ni, Mengqian
Xiang, Huiling
Li, Chunyan
Ou, Jinjing
Lin, Qingguang
Liu, Lixian
Tang, Guoxue
Luo, Rongzhen
An, Xin
Gao, Yi
Lin, Xi
SpringerLink (Online service)

Other Objects (12)

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review

BRCA germline mutation test for all woman with ovarian cancer?

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Germline Mutations Predispose to Pediatric Medulloblastoma

Radiomics to predict PNI in ESCC

Germline Mutations and Ancestry in Prostate Cancer

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review

BRCA germline mutation test for all woman with ovarian cancer?

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Germline Mutations Predispose to Pediatric Medulloblastoma

Radiomics to predict PNI in ESCC

Germline Mutations and Ancestry in Prostate Cancer

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review

BRCA germline mutation test for all woman with ovarian cancer?

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Germline Mutations Predispose to Pediatric Medulloblastoma

Radiomics to predict PNI in ESCC

Germline Mutations and Ancestry in Prostate Cancer

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review

BRCA germline mutation test for all woman with ovarian cancer?

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Germline Mutations Predispose to Pediatric Medulloblastoma

Radiomics to predict PNI in ESCC

Germline Mutations and Ancestry in Prostate Cancer

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review

BRCA germline mutation test for all woman with ovarian cancer?

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Germline Mutations Predispose to Pediatric Medulloblastoma

Radiomics to predict PNI in ESCC

Germline Mutations and Ancestry in Prostate Cancer

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review

BRCA germline mutation test for all woman with ovarian cancer?

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Germline Mutations Predispose to Pediatric Medulloblastoma

Radiomics to predict PNI in ESCC

Germline Mutations and Ancestry in Prostate Cancer

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

Related objects

Reset password